CompanyDeals

Medidata Partners with ECCO and GoBroad to Transform Cancer Trials with Digital Tech

CompanyDeals

Shanghai Circode Bio and Pfizer Collaborate to Explore Circular RNA Therapy Potential

CompanyDrug

Kedrion Biopharma Achieves First Product Approval in China for Human Albumin

CompanyDrug

GRIT Biotechnology’s GT201 TIL Therapy Approved for Clinical Studies by China’s CDE

CompanyDeals

Novartis Terminates TIGIT-Targeted Antibody Deal with BeiGene, Retains Rights to Ociperlimab

CompanyLegal / IP

Biocytogen Pharmaceuticals Awarded CNIPA Patent for RenMab Human Antibody Mice Platform

CompanyDeals

Guangdong’s OptoMedic Secures Over $27.8 Million in Pre-IPO Financing for Endoscopy Innovations

CompanyDrug

Jiangsu Hengrui Pharmaceuticals’ Irinotecan and Bupivacaine Liposome Injections Get Clinical Trial Green Light in China

CompanyDrug

Shanghai Junshi Biosciences’ Tuoyi Files for 9th Indication in China for RCC Treatment

CompanyDrug

Jiangsu Hengrui Pharmaceuticals Receives Clinical Trial Approvals for Irinotecan and Bupivacaine Liposome Injections

CompanyDrug

Shanghai Junshi Biosciences’ Tuoyi Files for 9th Indication in China for RCC Treatment

CompanyDeals

Next Generation Gene Therapeutics Secures $40 Million in Series B Financing for Gene Therapy Development